Quality control is one of those things that only a select few people pay attention to—until something goes wrong, then everyone cares. That's especially true in the drug manufacturing industry, where episodes like cross-contamination in a drug factory can shut down a production line and create instant shortages of important medicines. And if a contaminated medicines ever does get shipped out to clinics or stores, people’s lives can be at stake. So drug makers are usually pretty receptive toward any new technology that can help them detect manufacturing problems before they get out of hand. That’s the market opening that Harry's guest this week, Taylor Chartier, says she saw back in 2020, during the coronavirus pandemic. Chartier watched the stories about the Baltimore company Emergent BioSolutions, which was manufacturing vaccines for Johnson & Johnson and AstraZeneca and had to throw out millions of doses of both vaccines due to suspected cross-contamination, and thought: there has to be a better way. So she started her own company. And today her startup Modicus Prime is partnering with top pharma companies to use new machine vision and AI capabilities to catch drug manufacturing problems faster.